High-intensity Focused Ultrasound (HIFU) Therapy Market to Cross $398,724 Thousand, by 2025 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
pmrFebruary 15, 2021
(Feb 2021) The latest report published by Polaris Market Research, titled
“Global Tumor Ablation Market by Company, Region, Type and Application, Forecast for 2026” provides key information about the current status and prospects of the market. The report focuses on
market size, share, growth, emerging trends and market area analysis. The research also includes a comprehensive analysis of various market factors, including
market drivers, restrictions, trends, risks, and opportunities that are common in the market.
The report provides an in-depth analysis of the global Tumor Ablation market, which can help market participants design strategies and improve the profitability of their businesses. The study also outlines the major companies that exist in the market and their
News Highlights: Tissue Ablation Market Research Report by Technology, by indication, by type – General forecast until 2025
New York, January 29, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of the report “Tissue Ablation Market Research Report by Technology, by indication, by type – Global forecast to 2025 – Cumulative impact of COVID-19 ”- https://www.reportlinker.com/p06018567/?utm source=GNW
Market Statistics: The report provides market size and forecasts for five major currencies: USD, EUR GBP, JPY and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The global tissue ablation market is expected to grow from $ 15,706.23 million in 2020 to $ 21,630.47 million by the end of 2025.2. The global tissue ablation market is expected to grow from EUR 13,771.52 million in 2020 to EUR 18,966.01 million by the end of 2025. The global tissue ablation market is expected to grow from GBP 12,242.91
SonaCare Medical Announces Significant Publication of Focal Therapy Comparison to Radical Therapy
January 28, 2021
CHARLOTTE, NC, UNITED STATES, January 28, 2021 /EINPresswire.com/ SonaCare Medical, LLC, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report the publication of Focal Therapy Compared to Radical Prostatectomy for Non-Metastatic Prostate Cancer: A Propensity Score-Matched Study(1) just released in Nature. In this analysis, focal therapy and radical prostatectomy were compared using 1-to-1 propensity score-matched for treatment year, age, PSA, Gleason, T-Stage, cancer core length and neoadjuvant hormone use. At 3, 5 and 8 years Failure Free Survival (FFS) for radical prostatectomy was 86%, 82% and 79% compared to 91%, 86% and 83% FFS for focal therapy at the same time intervals. Also, of note the secondary treatment rates were approximately 16% for radical prostatectomy and approximately 17% for focal the
Fior Markets which is the fastest growing market research company. The report provides a comprehensive scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report features real-time developments in the global Tumor Ablation market encompasses a highly structured and comprehensive outlook of the market. It shows market types and applications that are categorized as ideal market segments. The report covers the competitive data analysis of the emerging and prominent players of the market. Along with this, it provides comprehensive data analysis on the risk factors, challenges, and possible new market avenues.